Rchr
J-GLOBAL ID：201801012233304642   Update date: Mar. 11, 2025

Eisuke Hida

ヒダ エイスケ | Eisuke Hida
Affiliation and department：
大阪大学 医学系研究科

About 大阪大学 医学系研究科


Job title： 特任教授(常勤)
Homepage URL  (1)： http://www2.med.osaka-u.ac.jp/biostat/grouptop
Research field  (1)： Statistical science
Research theme for competitive and other funds  (4)：
  • 2009 - 2012 Effects of new dietary lifestyle education program for metabolic syndrome patients based on randomized control trials
  • 2009 - 2011 A study of statistical science on health and culture : a cross-national study on dynamics of social disparity and life
  • 2008 - 2010 The effects of lifestyle modification on metabolic syndrome : a meta-analysis
  • 2008 - 2010 Statistical research on the design of clinical trials where the quantitative balance of benefits and risks is taken into account.
Papers (63)：
  • Hiroko Kaji, Tomoharu Yokooji, Takanori Taogoshi, Satoru Izumitani, Eisuke Hida, Hiroaki Matsuo. Assessment of Risk of Acidosis in Patients with Mild-to-Moderate Chronic Kidney Disease Treated with Intravenous Branched-Chain Amino Acid-Enriched Solution: A Propensity Score Matching Analysis. Biological & pharmaceutical bulletin. 2025. 48. 1. 46-50
  • Hirofumi Komaki, Eri Takeshita, Katsuhiko Kunitake, Takami Ishizuka, Yuko Shimizu-Motohashi, Akihiko Ishiyama, Masayuki Sasaki, Chihiro Yonee, Shinsuke Maruyama, Eisuke Hida, et al. Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy. Cell Reports Medicine. 2025. 6. 1. 101901-101901
  • Takuma Nakamura, Xin He, Noriaki Hattori, Eisuke Hida, Masayuki Hirata. Dilemma in patients with amyotrophic lateral sclerosis and expectations from brain-machine interfaces. Annals of medicine. 2024. 56. 1. 2386516-2386516
  • Makiko Maeda, Douglas Humber, Eisuke Hida, Tomohito Ohtani, Guannan Wang, Tong Wu, Shiori Takeda, Jacinta N Situ, Jun Hayashi, Shinpei Nonen, et al. Lower doses of carvedilol in Japanese heart failure patients with reduced ejection fraction could show the potential to be non-inferior to higher doses in US patients: An international collaborative observational study. PloS one. 2024. 19. 3. e0299510
  • Masayuki Nakamori, Daisaku Nakatani, Tomoharu Sato, Yuhei Hasuike, Seiko Kon, Toshio Saito, Harumasa Nakamura, Masanori P. Takahashi, Eisuke Hida, Hirofumi Komaki, et al. Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. eClinicalMedicine. 2024
ｍore...
MISC (16)：
ｍore...
Books (3)：
  • 臨床試験の事典
    朝倉書店 2023 ISBN:9784254322644
  • 社会調査事典
    丸善出版 2014 ISBN:4621087312
  • 医学統計学の事典
    朝倉書店 2010 ISBN:9784254121766
Education (3)：
  • 1999 - 2002 University of Tsukuba
  • 1997 - 1999 University of Tsukuba Graduate School, Division of Mathematics
  • 1993 - 1997 University of Tsukuba Graduate School, Division of Mathematics
Professional career (1)：
  • 博士(理学) (筑波大学)
Work history (8)：
  • 2018/10/01 - 現在 Osaka University Graduate School of Medicine Specially Appointed Professor
  • 2017/07/01 - 現在 Osaka University Osaka University Hospital
  • 2017/07/01 - 2018/09/30 Osaka University Graduate School of Medicine Associate Professor
  • 2014/04 - 2017/06 広島大学病院総合医療研究推進センター
  • 2011/01 - 2014/03 独立行政法人 医薬品医療機器総合機構
Show all
Association Membership(s) (4)：
The International Society for Clinical Biostatistics ,  The International Biometric Society ,  日本統計学会 ,  日本計量生物学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM